Wence Zhou

616 total citations
20 papers, 396 citations indexed

About

Wence Zhou is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Wence Zhou has authored 20 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Wence Zhou's work include Pancreatic and Hepatic Oncology Research (9 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wence Zhou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wence Zhou collaborates with scholars based in China, France and United States. Wence Zhou's co-authors include Shi Dong, Xin Li, Wenkai Jiang, Zhongtian Bai, Wenbo Meng, Zhengfeng Wang, Xun� Li, Xuan Zhang, Hui Zhang and Xun Li and has published in prestigious journals such as Frontiers in Immunology, Journal of Cellular Physiology and International Journal of Environmental Research and Public Health.

In The Last Decade

Wence Zhou

18 papers receiving 393 citations

Peers

Wence Zhou
Naveenkumar Perumal United States
Qian Zuo China
Ziqi Zhou China
Luoqi Jia China
Wence Zhou
Citations per year, relative to Wence Zhou Wence Zhou (= 1×) peers Shengjie Dai

Countries citing papers authored by Wence Zhou

Since Specialization
Citations

This map shows the geographic impact of Wence Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wence Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wence Zhou more than expected).

Fields of papers citing papers by Wence Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wence Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wence Zhou. The network helps show where Wence Zhou may publish in the future.

Co-authorship network of co-authors of Wence Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wence Zhou. A scholar is included among the top collaborators of Wence Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wence Zhou. Wence Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yongqing, et al.. (2025). The role of GPD2 and glycolysis-related genes in cholangiocarcinoma: insights into prognostic biomarkers and tumor-immune interactions. Cancer Cell International. 25(1). 345–345. 1 indexed citations
2.
Du, Yan, et al.. (2025). Pancreatic cancer subtyping - the keystone of precision treatment. Frontiers in Immunology. 16. 1563725–1563725. 2 indexed citations
3.
4.
Zhao, Yongqing, et al.. (2025). The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies. Cancer Cell International. 25(1). 360–360.
5.
Yi, Jianfeng, Zhenzhen Ye, Hao Xu, et al.. (2024). EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Phytomedicine. 135. 156137–156137. 13 indexed citations
6.
Han, Fangfang, et al.. (2024). Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.. PubMed. 37(2). 327–336.
7.
Xu, Ning, et al.. (2023). A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. Frontiers in Molecular Biosciences. 10. 1298077–1298077. 3 indexed citations
8.
Wang, Zhengfeng, et al.. (2023). Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy. Frontiers in Oncology. 13. 1185093–1185093. 7 indexed citations
9.
Jiang, Wenkai, et al.. (2023). The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. International Journal of Environmental Research and Public Health. 20(2). 1552–1552. 6 indexed citations
10.
Li, Xin, Yan Du, Wenkai Jiang, et al.. (2023). Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer. Frontiers in Immunology. 14. 1170223–1170223. 15 indexed citations
11.
Jiang, Wenkai, Xin Li, Shi Dong, & Wence Zhou. (2021). Betulinic acid in the treatment of tumour diseases: Application and research progress. Biomedicine & Pharmacotherapy. 142. 111990–111990. 97 indexed citations
12.
Meng, Wenbo, Joseph W. Leung, Ping Yue, et al.. (2019). Sa1486 IMPACT OF SIMULATION PRACTICE ON CLINICAL ERCP PERFORMANCE OF NOVICE ENDOSCOPISTS – A RCT USING ERCP MECHANICAL SIMULATOR (EMS). Gastrointestinal Endoscopy. 89(6). AB255–AB256. 2 indexed citations
13.
Zhang, Hui, Xuan Zhang, Xun Li, et al.. (2018). Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Journal of Cellular Physiology. 234(1). 619–631. 134 indexed citations
14.
Zhang, Hui, Xun� Li, Wenbo Meng, et al.. (2017). Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells. Molecular Medicine Reports. 17(2). 2614–2618. 2 indexed citations
15.
Bai, Zhongtian, Bing Bai, Jun Zhu, et al.. (2017). Epigenetic actions of environmental factors and promising drugs for cancer therapy (Review). Oncology Letters. 15(2). 2049–2056. 11 indexed citations
16.
Bai, Zhongtian, Zhengrong Wu, Lili Xi, et al.. (2016). Inhibition of invasion by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells. Bioorganic & Medicinal Chemistry Letters. 27(4). 989–993. 26 indexed citations
17.
Zhu, Xiaoliang, et al.. (2015). Malignant infiltrating intraductal papillary mucinous neoplasm with internal fistula: one case report and clinical practice.. PubMed. 8(11). 21732–6. 1 indexed citations
18.
Zhu, Kexiang, Yumin Li, Xun� Li, et al.. (2011). Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China. Molecular Biology Reports. 39(1). 723–728. 21 indexed citations
19.
Li, Yumin, et al.. (2010). Association between PARP-1 polymorphisms and susceptibility to gastric cancer. World Chinese Journal of Digestology. 18(14). 1434–1434. 4 indexed citations
20.
Zhang, Quanbao, Yumin Li, Xun� Li, et al.. (2008). PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. Molecular Biology Reports. 36(6). 1461–1467. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026